| . | Overall (n = 5070) . | Outpatient visits (n = 3638) . | Hospital admissions (n = 1432) . | p-value . |
|---|---|---|---|---|
| Age, years (mean ± SD) | 67.6 ± 10.5 | 67.2 ± 10.7 | 68.6 ± 9.9 | <0.0001 |
| Age >75 years, n (%) | 1283 (25.3) | 902 (24.8) | 381 (26.6) | 0.18 |
| Females, n (%) | 1008 (19.9) | 700 (19.2) | 308 (21.5) | 0.07 |
| BMI, kg/m2 (mean ± SD) | 27.3 ± 4.0 | 27.3 ± 4.0 | 27.5 ± 4.0 | 0.06 |
| Risk factors and comorbidities, n (%) | ||||
| Active smokers | 887 (17.5) | 637 (17.5) | 250 (17.5) | 0.97 |
| Hypercholesterolaemia | 3790 (74.8) | 2734 (75.2) | 1056 (73.7) | 0.30 |
| Diabetes mellitus | 1558 (30.7) | 1042 (28.6) | 516 (36.0) | <0.0001 |
| Hypertension | 4024 (79.4) | 2840 (78.1) | 1184 (82.7) | <0.001 |
| Chronic renal dysfunction | 602 (11.9) | 376 (10.3) | 226 (15.8) | <0.0001 |
| Peripheral artery disease | 451 (8.9) | 272 (7.5) | 179 (12.5) | <0.0001 |
| COPD | 603 (11.9) | 384 (10.6) | 219 (15.3) | <0.0001 |
| Sleep apnoea | 163 (3.2) | 115 (3.2) | 48 (3.3) | 0.73 |
| Malignancy | 331 (6.5) | 221 (6.1) | 110 (7.7) | 0.04 |
| Depression | 531 (10.5) | 397 (10.9) | 134 (9.4) | 0.10 |
| Cardiovascular history, n (%) | ||||
| Previous stroke/TIA | 276 (5.4) | 186 (5.1) | 90 (6.3) | 0.10 |
| History of major bleeding events | 95 (1.9) | 63 (1.7) | 32 (2.2) | 0.23 |
| History of heart failure | 680 (13.4) | 420 (11.5) | 260 (18.2) | <0.0001 |
| NYHA class III–IV | 153 (3.0) | 61 (1.7) | 92 (6.4) | <0.0001 |
| Prior STEMI | 1828 (36.1) | 1452 (39.9) | 376 (26.3) | <0.0001 |
| Previous revascularisation | 3966 (78.2) | 3048 (83.8) | 918 (64.1) | <0.0001 |
| . | Overall (n = 5070) . | Outpatient visits (n = 3638) . | Hospital admissions (n = 1432) . | p-value . |
|---|---|---|---|---|
| Age, years (mean ± SD) | 67.6 ± 10.5 | 67.2 ± 10.7 | 68.6 ± 9.9 | <0.0001 |
| Age >75 years, n (%) | 1283 (25.3) | 902 (24.8) | 381 (26.6) | 0.18 |
| Females, n (%) | 1008 (19.9) | 700 (19.2) | 308 (21.5) | 0.07 |
| BMI, kg/m2 (mean ± SD) | 27.3 ± 4.0 | 27.3 ± 4.0 | 27.5 ± 4.0 | 0.06 |
| Risk factors and comorbidities, n (%) | ||||
| Active smokers | 887 (17.5) | 637 (17.5) | 250 (17.5) | 0.97 |
| Hypercholesterolaemia | 3790 (74.8) | 2734 (75.2) | 1056 (73.7) | 0.30 |
| Diabetes mellitus | 1558 (30.7) | 1042 (28.6) | 516 (36.0) | <0.0001 |
| Hypertension | 4024 (79.4) | 2840 (78.1) | 1184 (82.7) | <0.001 |
| Chronic renal dysfunction | 602 (11.9) | 376 (10.3) | 226 (15.8) | <0.0001 |
| Peripheral artery disease | 451 (8.9) | 272 (7.5) | 179 (12.5) | <0.0001 |
| COPD | 603 (11.9) | 384 (10.6) | 219 (15.3) | <0.0001 |
| Sleep apnoea | 163 (3.2) | 115 (3.2) | 48 (3.3) | 0.73 |
| Malignancy | 331 (6.5) | 221 (6.1) | 110 (7.7) | 0.04 |
| Depression | 531 (10.5) | 397 (10.9) | 134 (9.4) | 0.10 |
| Cardiovascular history, n (%) | ||||
| Previous stroke/TIA | 276 (5.4) | 186 (5.1) | 90 (6.3) | 0.10 |
| History of major bleeding events | 95 (1.9) | 63 (1.7) | 32 (2.2) | 0.23 |
| History of heart failure | 680 (13.4) | 420 (11.5) | 260 (18.2) | <0.0001 |
| NYHA class III–IV | 153 (3.0) | 61 (1.7) | 92 (6.4) | <0.0001 |
| Prior STEMI | 1828 (36.1) | 1452 (39.9) | 376 (26.3) | <0.0001 |
| Previous revascularisation | 3966 (78.2) | 3048 (83.8) | 918 (64.1) | <0.0001 |
BMI: body mass index; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; MI: myocardial infarction; NYHA: New York Heart Association; STEMI: ST-elevation myocardial infarction; TIA: transient ischaemic attack.
| . | Overall (n = 5070) . | Outpatient visits (n = 3638) . | Hospital admissions (n = 1432) . | p-value . |
|---|---|---|---|---|
| Age, years (mean ± SD) | 67.6 ± 10.5 | 67.2 ± 10.7 | 68.6 ± 9.9 | <0.0001 |
| Age >75 years, n (%) | 1283 (25.3) | 902 (24.8) | 381 (26.6) | 0.18 |
| Females, n (%) | 1008 (19.9) | 700 (19.2) | 308 (21.5) | 0.07 |
| BMI, kg/m2 (mean ± SD) | 27.3 ± 4.0 | 27.3 ± 4.0 | 27.5 ± 4.0 | 0.06 |
| Risk factors and comorbidities, n (%) | ||||
| Active smokers | 887 (17.5) | 637 (17.5) | 250 (17.5) | 0.97 |
| Hypercholesterolaemia | 3790 (74.8) | 2734 (75.2) | 1056 (73.7) | 0.30 |
| Diabetes mellitus | 1558 (30.7) | 1042 (28.6) | 516 (36.0) | <0.0001 |
| Hypertension | 4024 (79.4) | 2840 (78.1) | 1184 (82.7) | <0.001 |
| Chronic renal dysfunction | 602 (11.9) | 376 (10.3) | 226 (15.8) | <0.0001 |
| Peripheral artery disease | 451 (8.9) | 272 (7.5) | 179 (12.5) | <0.0001 |
| COPD | 603 (11.9) | 384 (10.6) | 219 (15.3) | <0.0001 |
| Sleep apnoea | 163 (3.2) | 115 (3.2) | 48 (3.3) | 0.73 |
| Malignancy | 331 (6.5) | 221 (6.1) | 110 (7.7) | 0.04 |
| Depression | 531 (10.5) | 397 (10.9) | 134 (9.4) | 0.10 |
| Cardiovascular history, n (%) | ||||
| Previous stroke/TIA | 276 (5.4) | 186 (5.1) | 90 (6.3) | 0.10 |
| History of major bleeding events | 95 (1.9) | 63 (1.7) | 32 (2.2) | 0.23 |
| History of heart failure | 680 (13.4) | 420 (11.5) | 260 (18.2) | <0.0001 |
| NYHA class III–IV | 153 (3.0) | 61 (1.7) | 92 (6.4) | <0.0001 |
| Prior STEMI | 1828 (36.1) | 1452 (39.9) | 376 (26.3) | <0.0001 |
| Previous revascularisation | 3966 (78.2) | 3048 (83.8) | 918 (64.1) | <0.0001 |
| . | Overall (n = 5070) . | Outpatient visits (n = 3638) . | Hospital admissions (n = 1432) . | p-value . |
|---|---|---|---|---|
| Age, years (mean ± SD) | 67.6 ± 10.5 | 67.2 ± 10.7 | 68.6 ± 9.9 | <0.0001 |
| Age >75 years, n (%) | 1283 (25.3) | 902 (24.8) | 381 (26.6) | 0.18 |
| Females, n (%) | 1008 (19.9) | 700 (19.2) | 308 (21.5) | 0.07 |
| BMI, kg/m2 (mean ± SD) | 27.3 ± 4.0 | 27.3 ± 4.0 | 27.5 ± 4.0 | 0.06 |
| Risk factors and comorbidities, n (%) | ||||
| Active smokers | 887 (17.5) | 637 (17.5) | 250 (17.5) | 0.97 |
| Hypercholesterolaemia | 3790 (74.8) | 2734 (75.2) | 1056 (73.7) | 0.30 |
| Diabetes mellitus | 1558 (30.7) | 1042 (28.6) | 516 (36.0) | <0.0001 |
| Hypertension | 4024 (79.4) | 2840 (78.1) | 1184 (82.7) | <0.001 |
| Chronic renal dysfunction | 602 (11.9) | 376 (10.3) | 226 (15.8) | <0.0001 |
| Peripheral artery disease | 451 (8.9) | 272 (7.5) | 179 (12.5) | <0.0001 |
| COPD | 603 (11.9) | 384 (10.6) | 219 (15.3) | <0.0001 |
| Sleep apnoea | 163 (3.2) | 115 (3.2) | 48 (3.3) | 0.73 |
| Malignancy | 331 (6.5) | 221 (6.1) | 110 (7.7) | 0.04 |
| Depression | 531 (10.5) | 397 (10.9) | 134 (9.4) | 0.10 |
| Cardiovascular history, n (%) | ||||
| Previous stroke/TIA | 276 (5.4) | 186 (5.1) | 90 (6.3) | 0.10 |
| History of major bleeding events | 95 (1.9) | 63 (1.7) | 32 (2.2) | 0.23 |
| History of heart failure | 680 (13.4) | 420 (11.5) | 260 (18.2) | <0.0001 |
| NYHA class III–IV | 153 (3.0) | 61 (1.7) | 92 (6.4) | <0.0001 |
| Prior STEMI | 1828 (36.1) | 1452 (39.9) | 376 (26.3) | <0.0001 |
| Previous revascularisation | 3966 (78.2) | 3048 (83.8) | 918 (64.1) | <0.0001 |
BMI: body mass index; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; MI: myocardial infarction; NYHA: New York Heart Association; STEMI: ST-elevation myocardial infarction; TIA: transient ischaemic attack.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
